){kind=logo}
Key Findings in this Issue:
- FDA sends warning letters to companies who made claims on social media that their products treat, cure Ebola, marking the first time the Agency singles out Pinterest
- OIG issues special advisory bulletin and report emphasizing prohibition on copay coupons for Federally reimbursable medications (including Part D covered drugs), notes potential anti-kickback violations
- CMS rolls out Open Payments in effort to increase transparency and accountability